HighPoint Blog

Alexis Sharabaika, Senior Director Pricing, Contracting and Market Access

Senior Director, Pricing, Contracting and Market Access Mrs. Sharabaika is a Senior Director in the Pricing, Contracting and Market Access practice at HighPoint Solutions, focusing on strategy and technology solutions. Alexis has 14 years of Life Sciences industry experience with expertise in the government and commercial pricing space. Alexis’ pricing and contracting experience includes project management for enterprise wide system implementations as well as performing lead business architect functions specifically in GP, 340B, FSS, Medicaid and Tricare to support regulatory system processing, audits, policies and procedures work.
Find me on:

Recent Posts

On July 18, 2018, the FDA published its guidance for biosimilars, “Labeling for Biosimilar Products.” This guidance provides an overview of the FDA’s recommendations for biosimilar labeling, so that prescribers can make informed decisions. The FDA states the intent of the guidance is to help manufacturers “develop draft labeling for proposed biosimilar products for submission in an application...

Read More

The 340B Drug Discount Program (otherwise known as PHS program) was created in 1992 as a federally-funded program to provide reduced drug pricing to “safety net providers” that serve uninsured or vulnerable patients.  The concept was simple: Manufacturer drug pricing for covered outpatient drugs offered at extremely reduced prices—sometimes even at a penny—to eligible, qualified entities. The...

Read More

Special thanks to co-writer Neelabh Saxena, Associate Director Pricing, Contracting, and Market Access. 

Read More

Recent Posts

Tag